US Asset Management LLC’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340K Hold
678
0.26% 86
2026
Q1
$333K Sell
678
-8
-1% -$4.34K 0.29% 89
2025
Q4
$398K Sell
686
-8
-1% -$4.52K 0.32% 76
2025
Q3
$337K Hold
694
0.28% 83
2025
Q2
$281K Hold
694
0.24% 99
2025
Q1
$345K Sell
694
-5
-0.7% -$2.71K 0.33% 85
2024
Q4
$364K Sell
699
-42
-6% -$23.1K 0.33% 83
2024
Q3
$402K Sell
741
-3
-0.4% -$1.78K 0.36% 81
2024
Q2
$411K Sell
744
-16
-2% -$9.17K 0.37% 75
2024
Q1
$442K Sell
760
-328
-30% -$184K 0.4% 78
2023
Q4
$577K Buy
+1,088
New +$527K 0.57% 57
2023
Q2
$571K Sell
1,095
-1
-0.1% -$540 0.6% 48
2023
Q1
$632K Sell
1,096
-3
-0.3% -$1.69K 0.65% 38
2022
Q4
$605K Buy
+1,099
New +$582K 0.65% 42
2022
Q2
$597K Hold
1,099
0.66% 40
2022
Q1
$649K Sell
1,099
-100
-8% -$57.4K 0.6% 49
2021
Q4
$800K Sell
1,199
-1
-0.1% -$624 0.77% 42
2021
Q3
$686K Buy
+1,200
New +$659K 0.66% 41

Other funds holding TMO

US Asset Management LLC's TMO Position: Q2 2026 in Review

US Asset Management LLC held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 678 shares worth $340K. The position accounts for 0.26% of the portfolio, ranked #86.

US Asset Management LLC first reported a position in TMO in Q3 2021 and has held it in 18 quarters since. The position peaked at $800K in Q4 2021. 2,621 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • US Asset Management LLC held 678 shares of Thermo Fisher Scientific worth $340K as of Q2 2026.
  • US Asset Management LLC left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.26% of US Asset Management LLC's portfolio in Q2 2026, its #86 holding.
  • US Asset Management LLC first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 18 quarters since.
  • US Asset Management LLC's Thermo Fisher Scientific position peaked at $800K in Q4 2021.
  • 2,621 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on US Asset Management LLC's 13F filing for Q2 2026, filed 12 Aug 2026.